| 1 |
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
Kathryn E O'Reilly, F. Rojo, Qing‐Bai She et al. · Cancer Research
Open access |
Feb 2006 |
2,599 |
| 2 |
Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
David C. Lyden, Koichi Hattori, Sérgio Dias et al. · Nature Medicine
|
Nov 2001 |
1,864 |
| 3 |
Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors
Ricky T. Tong, Yves Boucher, Sergey V. Kozin et al. · Cancer Research
Open access |
Jun 2004 |
1,195 |
| 4 |
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
Bert Oosthuyse et al. · Nature Genetics
|
Jun 2001 |
1,016 |
| 5 |
Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
Monica Autiero et al. · Nature Medicine
|
8 Jun 2003 |
774 |
| 6 |
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment
Koichi Hattori, Beate Heissig, Yan Wu et al. · Nature Medicine
Open access |
Jul 2002 |
635 |
| 7 |
Anticancer Therapies Combining Antiangiogenic and Tumor Cell Cytotoxic Effects Reduce the Tumor Stem-Like Cell Fraction in Glioma Xenograft Tumors
Chris Folkins, Shan Man, Ping Xu et al. · Cancer Research
|
15 Apr 2007 |
384 |
| 8 |
Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1
Chris Folkins, Yuval Shaked, Shan Man et al. · Cancer Research
Open access |
8 Sep 2009 |
378 |
| 9 |
Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy
Larry Witte, Daniel J. Hicklin, Zhenping Zhu et al. · Cancer and Metastasis Reviews
Review |
Jun 1998 |
310 |
| 10 |
Vascular Endothelial Growth Factor Receptor-1 Activation Mediates Epithelial to Mesenchymal Transition in Human Pancreatic Carcinoma Cells
Anthony D. Yang, Ernest Ramsay Camp, Fan Fan et al. · Cancer Research
|
2006 |
291 |
| 11 |
Targeted Anti–Vascular Endothelial Growth Factor Receptor-2 Therapy Leads to Short-term and Long-term Impairment of Vascular Function and Increase in Tumor Hypoxia
Marcela Franco, Shan Man, Limor Chen et al. · Cancer Research
|
Apr 2006 |
162 |
| 12 |
Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies
Guido Bocci, Shan Man, Shane K. Green et al. · Cancer Research
|
15 Sep 2004 |
161 |
| 13 |
Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity
Z Zhu, Koichi Hattori, H Zhang et al. · Leukemia
|
Mar 2003 |
158 |
| 14 |
Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in β3-Integrin–Deficient Mice
Andrew R. Reynolds, Louise E. Reynolds, Tobi Nagel et al. · Cancer Research
Open access |
Dec 2004 |
154 |
| 15 |
Strategies for Delaying or TreatingIn vivoAcquired Resistance to Trastuzumab in Human Breast Cancer Xenografts
Jeanne M. du Manoir, Giulio Francia, Shan Man et al. · Clinical Cancer Research
Open access |
Feb 2006 |
144 |
| 16 |
A Comparative Analysis of Low-Dose Metronomic Cyclophosphamide Reveals Absent or Low-Grade Toxicity on Tissues Highly Sensitive to the Toxic Effects of Maximum Tolerated Dose Regimens
Urban Emmenegger, Shan Man, Yuval Shaked et al. · Cancer Research
|
Jun 2004 |
135 |
| 17 |
The myeloma cell antigen syndecan‐1 is lost by apoptotic myeloma cells
Michel Jourdan, Martine Ferlin, Éric Legouffe et al. · British Journal of Haematology
Open access |
Mar 1998 |
135 |
| 18 |
Angiogenesis Inhibition by Vascular Endothelial Growth Factor Receptor-2 Blockade Reduces Stromal Matrix Metalloproteinase Expression, Normalizes Stromal Tissue, and Reverts Epithelial Tumor Phenotype in Surface Heterotransplants
Silvia Vosseler, Nicolae Mirancea, Peter Böhlen et al. · Cancer Research
Open access |
15 Feb 2005 |
129 |
| 19 |
Role of an Anti-epidermal Growth Factor Receptor in Treating Cancer
Harlan W. Waksal · Cancer and Metastasis Reviews
Review |
Dec 1999 |
126 |
| 20 |
Polymorphisms inCyclooxygenase-2andEpidermal Growth Factor ReceptorAre Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab
Georg Lurje, Fumio Nagashima, Wu Zhang et al. · Clinical Cancer Research
Open access |
Dec 2008 |
115 |
| 21 |
Platelet-derived growth factor receptor-α: a novel therapeutic target in human hepatocellular cancer
Peggy Stock, Dulabh Kaur Monga, Xinping Tan et al. · Molecular Cancer Therapeutics
Open access |
30 Jun 2007 |
108 |
| 22 |
Development of Heparanase Inhibitors for Anti-Cancer Therapy
Zhenping Zhu, Elizabeth C. Navarro, Paul H. Kussie et al. · Current Medicinal Chemistry
|
24 Jul 2006 |
106 |
| 23 |
Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Fang Liao, Jacqueline F. Doody, Jay P. Overholser et al. · PubMed
|
May 2002 |
105 |
| 24 |
Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases
Thomas J. Kelly, Larry J. Suva, Yan Huang et al. · Cancer Research
Open access |
Jul 2005 |
104 |
| 25 |
Vascular endothelial growth factor receptor‐1 in human cancer
Jonathan D. Schwartz, Eric Keith Rowinsky, Hagop Youssoufian et al. · Cancer
Open access |
2 Feb 2010 |
95 |
| 26 |
Insulin-like Growth Factor-I Receptor Signaling Blockade Combined with Radiation
Gregory W. Allen, Corey Saba, Eric A. Armstrong et al. · Cancer Research
|
Feb 2007 |
94 |
| 27 |
Inhibition of Tumor Growth and Metastasis by Targeting Tumor-Associated Angiogenesis with Antagonists to the Receptors of Vascular Endothelial Growth Factor
Zhenping Zhu, Larry Witte · Investigational New Drugs
|
Aug 1999 |
94 |
| 28 |
Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature
Chad May, Jacqueline F. Doody, Rashed Abdullah et al. · Blood
|
9 Feb 2005 |
91 |
| 29 |
Monoclonal antibody therapeutics and apoptosis
Dale L. Ludwig, DANIEL SANTIAGO PEREIRA, Zhenping Zhu et al. · Oncogene
|
8 Dec 2003 |
83 |
| 30 |
Lack of detection of agonist activity by antibodies to platelet‐derived growth factor receptor α in a subset of normal and systemic sclerosis patient sera
Nick Loizos, Leah M. LaRiccia, Jami Weiner et al. · Arthritis & Rheumatism
|
30 Mar 2009 |
82 |
| 31 |
Immune Modulation with Thymosin Alpha 1 Treatment
R. King, Cynthia W. Tuthill · Vitamins and hormones
Book chapter |
2016 |
77 |
| 32 |
In vitro Procoagulant Activity Induced in Endothelial Cells by Chemotherapy and Antiangiogenic Drug Combinations: Modulation by Lower-Dose Chemotherapy
Li Ma, Giulio Francia, Alicia Viloria‐Petit et al. · Cancer Research
Open access |
15 Jun 2005 |
75 |
| 33 |
Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study
Kathleen M. Loomes, Robert H. Squires, Deirdre Anne Kelly et al. · Hepatology Communications
Open access |
4 May 2022 |
69 |
| 34 |
Activation of IKK by thymosin α1 requires the TRAF6 signalling pathway
Ping Zhang, Justin Chan, Ana‐Maria Dragoi et al. · EMBO Reports
Open access |
20 May 2005 |
62 |
| 35 |
Clinical Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor and Its Receptors as Cancer Therapeutics
Zhenping Zhu, Peter Böhlen, Larry Witte · Current Cancer Drug Targets
|
Jun 2002 |
62 |
| 36 |
Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro
Pieter Koolwijk, Erna Peters, B. van der Vecht et al. · Angiogenesis
|
Mar 2001 |
62 |
| 37 |
Fetal Stromal–Dependent Paracrine and Intracrine Vascular Endothelial Growth Factor-A/Vascular Endothelial Growth Factor Receptor-1 Signaling Promotes Proliferation and Motility of Human Primary Myeloma Cells
Loi͏̈c Vincent, David K. Jin, Matthias A. Karajannis et al. · Cancer Research
|
15 Apr 2005 |
60 |
| 38 |
The efficacy and safety of thymosin alpha‐1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial
S Iino, Jouji TOYOTA, H. Kumada et al. · Journal of Viral Hepatitis
|
4 Apr 2005 |
58 |
| 39 |
Effects of Arginine on Photostability and Thermal Stability of IgG1 Monoclonal Antibodies
Haripada Maity, Courtney O’Dell, Rahul Srivastava et al. · Current Pharmaceutical Biotechnology
|
29 Nov 2009 |
57 |
| 40 |
Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene
Dale L. Ludwig, Helen Kotanides, Thanh Thien Le et al. · Gene
|
May 2001 |
53 |
| 41 |
Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells
Matthias A. Karajannis, Loi͏̈c Vincent, Roberto DiRenzo et al. · Leukemia
|
6 Apr 2006 |
51 |
| 42 |
Single Variable Domain-IgG Fusion
Juqun Shen, Marie Danielle Vil, Xenia Jimenez et al. · Journal of Biological Chemistry
Open access |
16 Feb 2006 |
50 |
| 43 |
Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody
Zhenping Zhu, Dan Lu, Helen Kotanides et al. · Cancer Letters
|
Mar 1999 |
49 |
| 44 |
Inhibitory Anti-FLT3 Antibodies Are Capable of Mediating Antibody-Dependent Cell-Mediated Cytotoxicity and Reducing Engraftment of Acute Myelogenous Leukemia Blasts in Nonobese Diabetic/Severe Combined Immunodeficient Mice
Obdulio Piloto, Mark J. Levis, David L. Huso et al. · Cancer Research
|
15 Feb 2005 |
48 |
| 45 |
A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis*
Nael A. McCarty, Thomas A. Standaert, M. Teresi et al. · Pediatric Pulmonology
|
15 Jan 2002 |
48 |
| 46 |
Suppression of Ewing's Sarcoma Tumor Growth, Tumor Vessel Formation, and Vasculogenesis Following Anti–Vascular Endothelial Growth Factor Receptor-2 Therapy
Zhichao Zhou, Marcela Fabiana Bolontrade, Krishna Reddy et al. · Clinical Cancer Research
Open access |
15 Aug 2007 |
47 |
| 47 |
In vitro effect of thymosin‐α1 and interferon‐α on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
Pietro Andreoné, Carmela Cursaro, Annagiulia Gramenzi et al. · Journal of Viral Hepatitis
Open access |
May 2001 |
46 |
| 48 |
Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial
Simon Pacey, Mark J. Ratain, Keith T. Flaherty et al. · Investigational New Drugs
|
17 Dec 2009 |
46 |
| 49 |
Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth
Nancy Huang, Delia R. Bethell, Catherine M. Card et al. · In Vitro Cellular & Developmental Biology - Animal
Open access |
18 Sep 2008 |
45 |
| 50 |
Bead-to-bead transfer of chinese hamster ovary cells using macroporous microcarriers
Sten Ohlson, J. Branscomb, Karin Nilsson · Cytotechnology
|
1994 |
45 |